Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Society of Hematology (ASH)
Biotech
ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
While references to the Trump administration's attacks on science were prominent, an optimistic ASH was all about the data—and puppies.
Darren Incorvaia
Dec 9, 2025 3:15pm
ASH launches $12M fund for scientists who lose federal grants
Jun 10, 2025 4:32pm
ASH surveys identify barriers to improving diversity in research
Dec 16, 2024 5:10pm
45 days later, BioCryst abandons another drug, citing competition
Dec 15, 2022 10:29am
ASH: Regeneron lymphoma med scores but safety muffles excitement
Dec 12, 2022 5:30pm
ASH: Senti Bio's CAR-NK therapy shows promise in leukemia
Dec 9, 2021 9:05am
